tradingkey.logo
tradingkey.logo
Search

Oric Pharmaceuticals Inc

ORIC
Add to Watchlist
11.070USD
-0.570-4.90%
Close 07-31 16:00ETQuotes delayed by 15 min
1.15BMarket Cap
LossP/E TTM

ORIC Financials

See Oric Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Oric Pharmaceuticals Inc Earnings Date

Latest Release
May 4, 2026
EPS / Forecast
-0.34/-0.32
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.47
19.57%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
19.75%-0.34
42.22%-0.30
32.79%-0.33
-2.42%-0.47
-13.80%-0.42
-4.35%-0.51
-10.40%-0.49
9.59%-0.45
30.07%-0.37
5.21%-0.49
---0.44
---0.50
---0.53
---0.52
---1.73
----
----
----
----
----
Net Profit
-19.14%-35.77M
15.98%-30.50M
5.73%-32.59M
-13.74%-36.35M
-20.03%-30.02M
-28.16%-36.31M
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
-40.28%-23.16M
19.42%-22.77M
27.88%-18.43M
-90.58%-21.01M
Operating profit
-21.09%-39.62M
12.68%-34.55M
4.30%-36.67M
-8.46%-39.06M
-12.86%-32.72M
-25.91%-39.57M
-33.60%-38.32M
-44.11%-36.02M
-12.90%-28.99M
-42.09%-31.43M
-38.60%-28.68M
-20.76%-24.99M
-10.41%-25.68M
3.01%-22.12M
-12.13%-20.69M
1.71%-20.70M
-40.51%-23.26M
-38.97%-22.80M
-46.12%-18.46M
-89.31%-21.06M
Net Profit
-19.14%-35.77M
15.98%-30.50M
5.73%-32.59M
-13.74%-36.35M
-20.03%-30.02M
-28.16%-36.31M
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
-40.28%-23.16M
19.42%-22.77M
27.88%-18.43M
-90.58%-21.01M
Current assets
37.27%290.23M
10.00%288.47M
5.79%295.59M
-1.18%291.12M
-34.76%211.43M
23.36%262.25M
20.32%279.43M
9.78%294.60M
67.78%324.08M
1.02%212.60M
16.89%232.24M
14.92%268.36M
-19.21%193.16M
-12.50%210.46M
-32.15%198.69M
-11.86%233.53M
-14.64%239.09M
-18.93%240.52M
54.90%292.85M
32.99%264.95M
Total current liabilities
0.87%17.77M
-17.83%20.42M
-5.03%20.18M
-7.62%18.05M
15.83%17.62M
21.45%24.85M
12.16%21.25M
34.44%19.54M
2.31%15.21M
32.95%20.46M
42.61%18.94M
16.51%14.53M
25.81%14.87M
1.56%15.39M
11.60%13.28M
25.95%12.47M
53.95%11.82M
68.31%15.15M
71.81%11.90M
71.41%9.90M
Total assets
79.84%436.76M
49.15%408.89M
42.75%431.19M
5.46%346.86M
-30.77%242.86M
8.78%274.14M
10.11%302.07M
12.71%328.91M
54.77%350.79M
1.95%252.01M
15.27%274.33M
12.37%291.82M
-17.60%226.65M
-17.23%247.18M
-24.25%238.00M
-3.18%259.68M
-3.13%275.06M
-0.12%298.64M
63.92%314.18M
33.10%268.23M
Total liabilities
-8.28%21.20M
-20.93%24.53M
-13.55%24.27M
-13.75%22.86M
4.42%23.12M
11.11%31.02M
4.29%28.08M
15.16%26.51M
-7.11%22.14M
12.45%27.92M
16.15%26.92M
0.89%23.02M
8.43%23.84M
-3.27%24.83M
2.36%23.18M
130.35%22.81M
178.80%21.98M
178.34%25.67M
210.75%22.64M
57.76%9.90M
Total equity
89.11%415.56M
58.09%384.36M
48.51%406.92M
7.14%324.00M
-33.14%219.74M
8.49%243.12M
10.74%273.99M
12.50%302.40M
62.04%328.64M
0.78%224.09M
15.17%247.41M
13.48%268.80M
-19.86%202.81M
-18.55%222.35M
-26.31%214.82M
-8.30%236.87M
-8.33%253.08M
-5.80%272.98M
58.12%291.54M
32.31%258.32M
Net operating income
0.29%-32.44M
19.86%-22.48M
12.80%-25.11M
-20.36%-30.84M
-7.78%-32.53M
-15.59%-28.05M
-46.59%-28.80M
-21.19%-25.63M
-46.34%-30.19M
-58.33%-24.27M
-1.68%-19.64M
-18.95%-21.14M
9.20%-20.63M
5.86%-15.33M
-59.12%-19.32M
-9.63%-17.78M
-52.46%-22.72M
8.65%-16.28M
-26.74%-12.14M
-69.18%-16.21M
Net investment
-180.07%-17.98M
-60.18%16.98M
-579.13%-110.53M
-520.84%-76.93M
136.29%22.45M
103.48%42.66M
139.89%23.07M
194.65%18.28M
-584.18%-61.87M
-25.93%20.96M
-8342.48%-57.83M
58.20%-19.31M
114.09%12.78M
7962.68%28.30M
-101.95%-685.00K
-156.10%-46.20M
-323.04%-90.66M
100.38%351.00K
128.13%35.07M
40874.75%82.36M
Net financing
555718.18%61.14M
160.87%1.50M
86765.87%109.45M
16358.58%134.30M
-99.99%11.00K
26.93%575.00K
306.45%126.00K
-99.04%816.00K
--125.03M
-98.17%453.00K
3000.00%31.00K
20423.86%85.17M
-100.00%0.00
2949.57%24.79M
-100.00%1.00K
247.69%415.00K
0.00%16.00K
-99.35%813.00K
14348.09%48.59M
-100.22%-281.00K

FAQs

What are the current assets of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its current assets were 288.47M, with a year-on-year change of 10.00.

What are the total assets of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its total assets of Oric Pharmaceuticals Inc were 408.89M, with a year-on-year change of 49.15.

What are the total liabilities of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Oric Pharmaceuticals Inc were 24.53M, with a year-on-year change of -20.93.

What is the total equity of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its total equity of Oric Pharmaceuticals Inc was 384.36M, with a year-on-year change of 58.09.

What is the net operating income of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Oric Pharmaceuticals Inc was -143.00M, with a year-on-year change of -0.08.

What is the net investment of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its net investment of Oric Pharmaceuticals Inc was -148.03M, with a year-on-year change of -768.70.

What is the net financing of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its net financing of Oric Pharmaceuticals Inc was 245.26M, with a year-on-year change of 93.81.

What is the Earnings Per Share (EPS) of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.47, with a year-on-year change of 19.57.

What is the net income of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its net income was -129.47M, with a year-on-year change of -1.27.

What is the Return on Equity (ROE) of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -41.27, with a year-on-year change of 24.60.

What is the Return on Assets (ROA) of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -37.91, with a year-on-year change of 21.99.

What is the operating profit of Oric Pharmaceuticals Inc?

According to Oric Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -143.00M, with a year-on-year change of -0.08.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.